Roth Capital Starts AMAG Pharmaceuticals (AMAG) at Buy
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 15 | New: 50
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 15 | New: 50
Join SI Premium – FREE
Roth Capital initiates coverage on AMAG Pharmaceuticals (NASDAQ: AMAG) with a Buy rating and $25 price target.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.33 yesterday.
For more ratings news on AMAG Pharmaceuticals click here and for the rating history of AMAG Pharmaceuticals click here.
Shares of AMAG Pharmaceuticals closed at $17.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lucid Capital Markets Starts Service Properties Trust (SVC) at Buy
- RBC Capital Assumes Roper Industries (ROP) at Sector Perform
- TD Cowen Starts IQM Quantum Computers (IQMX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
